Skip to main content

News

22 November 2022

Professor Malin Lindstedt obtained a new grant from The Swedish cancer society (Cancerfonden) for a project focused on the function and prognostic impact of myeloid cells in the tumor microenvironment of Head and Neck cancer (2 400 000 SEK).

14 November 2022

The nomenclature subcommittee on immunoglobulin, T cell receptor and MHC of the International Union of Immunological Societies (IUIS) has been restructured.

11 October 2022

Associate Professor Kristina Lundberg has received a grant (1.5 mil SEK) from Ingabritt and Arne Lundbergs foundation for purchasing a multiparameter flow cytometer with capacity to sort cells.

15 September 2022

Finally there is a resource to enable proper sequence analysis of antibody responses in the commonly used Balb/c mouse strain.

25 May 2022

In collaboration with Assoc. Prof Marika Nestor (Uppsala University) the facilities of SciLifeLab's Drug Discovery and Development Platform, including the Human Antibody Therapeutics unit at the Dept. of Immunotechnology, have co-developed an antibody-based radiopharmaceutical intended for treatment of advanced thyroid cancer. The project now exits [...]

17 March 2022

Professor Malin Lindstedt has received a Strategic Mobility Grant (1.24 MSEK) from the Swedish Foundation for Strategic Research. She will work part-time at Alligator Bioscience AB in Lund during 2022-2023 within the field of cancer immunotherapies.

8 November 2021

Associate Professor (Docent) Magnus Jakobsson from the Dept. of Immunotechnology today received a grant of 4.0 MSEK from the Swedish Research Council to fund exploratory research on protein regulation through so-called post-translational modification (PTM) in human health and disease.

18 October 2021

“Cells synthesize proteins from a DNA template and expand their biochemical repertoire through dynamic and enzyme-catalysed post-translational modifications (PTM). Methylation of the amino acid histidine was first reported in the late 1960s but until recently very little was known about its enzymology, extent and function.

9 June 2021

Professor Sara Ek has received 1.2 MSEK in support from LTH to participate in the LU Agenda 2030 research school with the project “ Deepened understanding of the connection between symptoms, psychological resilience and molecular factors in patients with chronic skin cancer” . The project is connected to an ongoing clinical trial, BIO-MUSE, headed [...]

26 May 2021

The parties have signed a 5-year collaboration agreement. Focus will be on recruitment of PhD students to cancer research at Lund University, exchange of physicians within oncology between Skåne University Hospital and TMUCIH, as well as joint research projects. One of the first projects, is led by Prof. Sara Ek and Lecturer Dr Anna Gerdtsson at [...]

Page Manager: jana.hagman@immun.lth.se | 2022-11-21